GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMOP.PFD) » Definitions » Cash Ratio

Avid Bioservices (Avid Bioservices) Cash Ratio : 0.14 (As of Jan. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Avid Bioservices Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Avid Bioservices's Cash Ratio for the quarter that ended in Jan. 2024 was 0.14.

Avid Bioservices has a Cash Ratio of 0.14. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Avid Bioservices's Cash Ratio or its related term are showing as below:

CDMOP.PFD' s Cash Ratio Range Over the Past 10 Years
Min: 0.39   Med: 1.13   Max: 3.49
Current: 0.41

During the past 13 years, Avid Bioservices's highest Cash Ratio was 3.49. The lowest was 0.39. And the median was 1.13.

CDMOP.PFD's Cash Ratio is ranked worse than
84.79% of 1525 companies
in the Biotechnology industry
Industry Median: 2.95 vs CDMOP.PFD: 0.41

Avid Bioservices Cash Ratio Historical Data

The historical data trend for Avid Bioservices's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Cash Ratio Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 0.82 2.40 1.67 0.52

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.52 0.39 0.41 0.14

Competitive Comparison of Avid Bioservices's Cash Ratio

For the Biotechnology subindustry, Avid Bioservices's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's Cash Ratio falls into.



Avid Bioservices Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Avid Bioservices's Cash Ratio for the fiscal year that ended in Apr. 2023 is calculated as:

Cash Ratio (A: Apr. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=38.542/73.709
=0.52

Avid Bioservices's Cash Ratio for the quarter that ended in Jan. 2024 is calculated as:

Cash Ratio (Q: Jan. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=30.708/222.887
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avid Bioservices  (NAS:CDMOP.PFD) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Avid Bioservices Cash Ratio Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (Avid Bioservices) Business Description

Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Avid Bioservices (Avid Bioservices) Headlines

From GuruFocus